Multiple myeloma (MM) is a plasma cell disorder accounting for approximately 10% of
hematologic malignancies. There is limited epidemiological evidence regarding the long …

Background: Monoclonal gammopathy of undetermined significance (MGUS) is a precursor
of multiple myeloma (MM) and related conditions. In previous registry-based, retrospective …

Monoclonal gammopathies are a spectrum of disorders caused by aberrant clonal
proliferation of plasma cells or B lymphocytes. Monoclonal gammopathy of undetermined …

The diagnosis of multiple myeloma requires detection of paraproteinemia and confirmation
of monoclonal bone marrow infiltration, along with signs of end-organ damage. Despite the …

Novel therapies for multiple myeloma have substantially improved the prognosis, but before
patients are able to benefit from treatment, a diagnosis must have been made. The Myeloma …

Los pacientes infectados por SARS-CoV-2 presentan un curso clínico variable, desde
asintomáticos o con síntomas respiratorios leves hasta una evolución grave con gran …

There is some evidence that a prior cancer is a risk factor for the development of multiple
myeloma (MM). If this is true, prior cancer should be associated with higher prevalence or …